Search Results

Site Search

Genetics events - Insights

For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose. To provide meaningful answers, our...

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Gastroenterology - Insights

Mayo Clinic has been recognized as the No. 1 gastroenterology and gastrointestinal surgery hospital in the nation by U.S. News & World Report every year since 1990. Backed by the experience and knowledge of more than 140 digestive disease...

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Justin Kreuter, M.D., Featured on Mayo Clinic Radio to Discuss New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights

On the Sept. 2 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Justin Kreuter, M.D., Medical Director of Mayo’s Blood Donor Program, about new eligibility guidelines for blood donors with previous...

Mayo Clinic Laboratory and pathology research roundup: August 1 - Insights

This week's research roundup feature: A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling.

Autoimmune Gastrointestinal Dysmotility Evaluation [Test in Focus] - Insights

Divyanshu (Div), Dubey, M.B.B.S, gives an overview of the new Autoimmune Gastrointestinal Dysmotility Evaluation available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to...

Histiocytic neoplasms - Insights

Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.

Scope of Services – Laboratory Medicine and Pathology [RDLMP.POL-63851]

Mayo Clinic Laboratories Scope of Services- Laboratory Medicine and Pathology PURPOSE The purpose of this document is to provide a written definition of the activities performed by the Department of Laboratory Medicine and...